Circulating Biomarkers In Migraine. New Opportunities For Precision Medicine.

Conclusion The characterization of migraine specific biomarkers would be fundamental in a perspective of precision medicine, enabling risk assessment and tailored treatments. However, speculating on the clinical validity of migraine biomarkers may be premature and controlled clinical trials are presently needed to investigate both the diagnostic and therapeutic value of these biomarkers in migraine.
PMID: 29932027 [PubMed - as supplied by publisher]

Source: Current Medicinal Chemistry - June 22, 2018 Category: Chemistry Authors: Ferroni P, Barbanti P, Spila A, Fratangeli F, Aurilia C, Fofi L, Egeo G, Guadagni F Tags: Curr Med Chem Source Type: research